Schond Greenway
2022 - Mind Medicine (MindMed)
In 2022, Schond Greenway earned a total compensation of $2.1M as Chief Financial Officer at Mind Medicine (MindMed).
Compensation breakdown
| Non-Equity Incentive Plan | $97,316 |
|---|---|
| Option Awards | $828,708 |
| Salary | $243,056 |
| Stock Awards | $976,164 |
| Other | $2,911 |
| Total | $2,148,155 |
Greenway received $976.2K in stock awards, accounting for 45% of the total pay in 2022.
Greenway also received $97.3K in non-equity incentive plan, $828.7K in option awards, $243.1K in salary and $2.9K in other compensation.
Rankings
In 2022, Schond Greenway's compensation ranked 1,660th out of 5,759 executives tracked by ExecPay. In other words, Greenway earned more than 71.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,660 out of 5,759 | 71st |
Division Manufacturing | 862 out of 3,135 | 73rd |
Major group Chemicals And Allied Products | 341 out of 1,421 | 76th |
Industry group Drugs | 315 out of 1,322 | 76th |
Industry Medicinal Chemicals and Botanical Products | 9 out of 34 | 74th |
Source: SEC filing on April 26, 2024.
Greenway's colleagues
We found two more compensation records of executives who worked with Schond Greenway at Mind Medicine (MindMed) in 2022.